About C4 Imaging
C4 Imaging is a Healthcare company based in Bellaire (United States) founded in 2009. It operates as an image-guided procedures for prostate cancer treatment are provided. C4 Imaging has raised $7.35 million across 8 funding rounds from investors including NIH, HHS and Stoneworth Financial. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is C4 Imaging LLC. Its competitors include Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and Concure Oncology and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
C4 Imaging was founded in 2009 and is based in Bellaire, United States. Operations focus on the medical imaging sector, where proprietary C4 technologyan MRI agent encapsulated in an implantable, biocompatible shellis developed. The initial product, Sirius MRI Marker, is utilized for seed localization in prostate cancer brachytherapy. Accurate positioning of seeds within prostate anatomy and adjacent structures is enabled through a single post-implant MR imaging session.
- Headquarters Bellaire, United States
- SectorsHealthcare
- Website c4imaging.com
- Social LinkedIn Facebook
- Legal Name C4 Imaging Llc.
- Total Equity Funding$7.35M (USD)
in 8 rounds
- Latest Funding Round$1.5M (USD), Seed
Feb 2024
- InvestorsNIH
& 2 more
Funding Insights of C4 Imaging
C4 Imaging has successfully raised a total of $7.35M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.35M
- Total Rounds 8
- Last Round Seed — $1.5M
- First Round $2M
(Feb 2010)
- Investors Count 3
All 8 funding rounds of C4 Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $1.5M | Seed | – | – | – |
| Feb 2021 | – | Seed | – | Stoneworth Financial | – |
| Jun 2018 | $1.2M | Seed | – | – | – |
| Oct 2016 | $1.1M | Seed | – | – | – |
| Aug 2015 | $1.32M | Grant | – | – | |
| Aug 2013 | $1.55M | Seed | – | – | – |
| Sep 2010 | $155,758 | Grant | – | – | |
| Feb 2010 | $2M | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in C4 Imaging
C4 Imaging has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Stoneworth Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are provided to maximize owner value. | 2016 | stoneworth.com | Houston, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for C4 Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of C4 Imaging
4 people are tracked at C4 Imaging (3 in leadership, 1 in board & advisors).
| Name | Role | Group |
|---|---|---|
Andrew Bright | CEO & President | Leadership |
Roy Markham | Eastern Regional Sales Director | Leadership |
Penny Tomlinson | Western Zone Regional Sales Director | Leadership |
Steven J. Frank | Founder | Board & advisors |
Complete people profiles for C4 Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of C4 Imaging
3 dated milestones of C4 Imaging across 15 years, from founding to its latest funding, stage changes and deals.
- Founded C4 Imaging is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Seed, of $1.5M.
Competitors of C4 Imaging
C4 Imaging has 7 listed competitors in our database, 6 of them funded. They include Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and Concure Oncology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| koyamedical.com | 2018 | Oakland, United States | $37.02M | 122 | Provider of smart wearable compression technology for lymphedema and venous diseases | |
| sensushealthcare.com | 2010 | Boca Raton, United States | $12.24M | 42 | Non-invasive skin cancer treatments are developed and marketed. | |
| theragenics.com | 1981 | Buford, United States | $9.44M | 566 | Manufacturer of surgical products and brachytherapy devices | |
| bebig.com | 1997 | Seneffe, Belgium | – | – | Brachytherapy devices are developed for prostate, breast, and gynecological cancers. | |
| breastmicroseed.com | 2014 | Mercer Island, United States | $14.04M | – | Breast microseed radiotherapy for early-stage breast cancer is developed. | |
| radiogel.com | 2006 | Richland, United States | $725,000 | – | Yttrium-90 brachytherapy devices for cancer treatment are developed. | |
| civatechoncology.com | 2006 | Durham, United States | $12.4M | – | Polymer-based devices for low-dose brachytherapy in solid tumors are provided. |
Detailed competitors of C4 Imaging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of C4 Imaging
Websites that share an audience with C4 Imaging (c4imaging.com).
Websites whose visitors overlap most with C4 Imaging. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Oncology
10 companies that operate in the same segment as C4 Imaging (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about C4 Imaging
Complete news archive for C4 Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C4 Imaging
C4 Imaging was founded in 2009 and raised its 1st funding round 1 year after it was founded.
C4 Imaging is headquartered in Bellaire, United States. It is registered at Bellaire, Texas, United States.
C4 Imaging is a funded company, having raised a total of $7.35M across 8 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Feb 2010.
C4 Imaging was founded in 2009 and is based in Bellaire, United States. Operations focus on the medical imaging sector, where proprietary C4 technologyan MRI agent encapsulated in an implantable, biocompatible shellis developed. The initial product, Sirius MRI Marker, is utilized for seed localization in prostate cancer brachytherapy. Accurate positioning of seeds within prostate anatomy and adjacent structures is enabled through a single post-implant MR imaging session.
C4 Imaging's top competitors include Koya Medical, Sensus Healthcare and RadioGel.
C4 Imaging has 3 investors. Key investors include NIH, HHS, and Stoneworth Financial.
C4 Imaging operates through C4 Imaging Llc..